BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
PBX1
,
glucose metabolic process
,
Leukemia
,
Endothelial cell
,
Biofuel
,
Vitamin E
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
c JUN
Summary
General Info
Curated Studies
Most Correlated Studies
Prostate cancer cells (PC3) with shRNA targeting c-JUN or JUND
LNCaP cell line expression with siRNA knockdown of COP1, ETV1, and/or c-JUN
Schwann cells from c-Jun knockout mice with and without sciatic nerve injury
AP-1 Transcription Factor c-Jun prevents Stress-Imposed Maladaptive Remodeling of heart
L1000 CMAP - Embryonic kidney 293T cells with shRNA-mediated gene knockdown
Explore Curated Studies Results
Literature
Most Relevant Literature
c-JUN is a barrier in hESC to cardiomyocyte transition.
Drug Screening for Hepatitis A Virus (HAV): Nicotinamide Inhibits c-Jun Expression and HAV Replicati…
Targeting c-Jun Is a Potential Therapy for Luminal Breast Cancer Bone Metastasis.
PU.1-c-Jun interaction is crucial for PU.1 function in myeloid development.
Reactions of Arsenoplatin-1 with Protein Targets: A Combined Experimental and Theoretical Study.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Study of the Effect of Vinca Alkaloids on c-Jun N-terminal Kinase (JNK) Phosphorylation in Patient…
Efficacy of Injectable Vitamin C on Accelerating Canine Movement: A Clinical Study
Detection of Hepatitis C Infection by Oraquick Test Among Health Care Workers
Efficacy and Safety Study of Ursodeoxycholic Acid to Treat Chronic Hepatitis C
TACE+Tilelizumab+Sorafenib in the Treatment of BCLC Stage C HCC
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ